Integrated analysis of MYC expression, 8q24.21 copy number, and recurrence patterns in astrocytoma, IDH-mutant
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Astrocytomas show increased 8q24.21 copy number associated with remote recurrence. MYC expression, while frequent, did not correlate with 8q gain or recurrence patterns in this study.
Area Of Science
- Neuro-oncology
- Genetics
- Cancer Biology
Background
- Astrocytomas exhibit a higher frequency of intracranial remote recurrence than oligodendrogliomas.
- Gain of chromosome 8q, especially the terminal region, is a known poor prognostic factor.
Purpose Of The Study
- To investigate MYC expression and its correlation with 8q24.21 copy number gain.
- To determine the relationship between MYC alterations and recurrence patterns, specifically intracranial remote recurrence in astrocytomas.
Main Methods
- Retrospective analysis of 27 astrocytoma patients (2006-2019).
- MYC expression assessed via immunohistochemistry (IHC).
- Copy number status evaluated using metaphase comparative genomic hybridization and next-generation sequencing.
Main Results
- MYC expression was detected in 72% of 43 analyzed specimens, with higher rates in recurrent (80%) vs. initial (61%) samples, not statistically significant.
- Significant increase in 8q24.21 copy number observed in specimens with remote recurrence compared to local recurrence (p=0.033).
- No significant correlation found between MYC copy number and protein expression (p=0.055).
Conclusions
- MYC is frequently expressed in astrocytomas, but its expression level does not reliably reflect 8q gain.
- Increased 8q24.21 copy number is associated with remote recurrence in astrocytomas.
- MYC expression alone is not a significant predictor of recurrence patterns in astrocytomas.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
